To further expand trading opportunities and enhance your Futures trading experience, MEXC will launch KRMN, ENPH, NTRA, SKDD and SKUU Stock Futures on the Futures market. These new listings offer a flexible and efficient way to gain exposure to some of the most prominent equities. Futures trading will be available immediately upon listing, with Futures Grid Bot strategies available within 5 minutes of listing.

Futures Trading Details

Introduction

KRMN: Karman Holdings Inc., through its subsidiaries, designs, tests, manufactures, and markets mission-critical systems in the United States. The company provides payload protection and deployment systems, aerodynamic mid-stage systems, and propulsion systems. Its products serve the hypersonic and strategic missile defense, tactical missile and integrated defense systems, and the space and launch markets. Founded in 2020, the company is headquartered in Huntington Beach, California.

ENPH: Enphase Energy, Inc. and its subsidiaries design, develop, manufacture, and market home energy solutions for the solar photovoltaic industry, operating in the U.S. and international markets. The company offers semiconductor-based microinverters capable of converting energy at the single solar module level, combined with its proprietary networking and software technologies for energy monitoring and control. It also provides microinverter units and related accessories; IQ batteries and related accessories; IQ PowerPack 1500 and related accessories; IQ combiners, IQ gateways, and IQ energy routers; cloud-based monitoring services; electric vehicle charging solutions; and design, proposal, licensing, installation, and solar appointment generation services, as well as Enphase Care services. The company sells its solutions to solar distributors; directly to large installers, original equipment manufacturers, strategic partners, and homeowners; and through its traditional product upgrade programs or online store.

NTRA：Natera, Inc. is a diagnostics company focused on the development and commercialization of molecular diagnostic services worldwide. It offers Signatera, a personalized ctDNA blood test for assessing minimal residual disease (MRD), monitoring early recurrence, and evaluating treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue-based comprehensive genomic analysis test; and Empower, a genetic cancer screening test. The company also offers Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT (non-invasive prenatal genetic test) for screening 21 single-gene genetic diseases; and Vistara, a single-gene NIPT for screening 25 single-gene diseases. In addition, it offers Anora, which detects and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a genetic cancer screening test; Prospera, a test to assess active rejection in patients receiving solid organ transplants; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model.

SKDD: Designed to provide -2x inverse leveraged returns of SK Hynix stock's daily price movements, this is a single-day short leveraged ETF under GraniteShares. It is suitable for investors with a short-term bearish outlook on SK Hynix for tactical allocation.

SKUU: Designed to provide twice the daily leveraged returns of SK Hynix stock, this is a single-day long leveraged ETF under GraniteShares. It is suitable for investors with a short-term bullish outlook on SK Hynix for tactical allocation.

🎉 Limited-Time Offer: Enjoy 0 Trading Fees